BUZZ--美國股票走勢-諾和諾德、TechTarget、Unicycive Therapeutics

路透中文

06/10

BUZZ--美國股票走勢-<a href="https://laohu8.com/S/NVO">諾和諾德</a>、<a href="https://laohu8.com/S/TTGT">TechTarget</a>、Unicycive <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

個股走勢的 Eikon 搜索字符串：STXBZ

The Day Ahead時事通訊：https://refini.tv/3LI4BU7

新聞早報》通訊：https://refini.tv/3dKUyB8

6月10日 - 美國股指期貨週二升跌不一，投資者在等待美國和中國之間正在進行的貿易談判的結果 (link)，談判旨在為今年以來令全球市場遭受重創的關稅爭端降溫。 .N

** Novo Nordisk A/S < NVO.N (link) >:BUZZ - 在有關Parvus建築股份的報告發布後，股價上漲。 nL8N3SD0CF

** TechTarget Inc < TTGT.O (link) >:BUZZ - JP 摩根大通下調評級後股價下跌 nL4N3SD0JU

** Unicycive Therapeutics Inc < UNCY.O (link) >:BUZZ - 因 FDA 指出腎病藥物存在生產問題而暴跌 nL4N3SD0NU

** Recursion Pharmaceuticals Inc < RXRX.O (link) >:BUZZ - 在裁員 20% 後上漲 nL4N3SD0OS

** J.M. Smucker Co < SJM.N (link) >:BUZZ - 在下調年度盈利預測後下跌 nL6N3SD0II

(為便利非英文母語者，路透將其報導自動化翻譯為數種其他語言。由於自動化翻譯可能有誤，或未能包含所需語境，路透不保證自動化翻譯文本的準確性，僅是為了便利讀者而提供自動化翻譯。對於因為使用自動化翻譯功能而造成的任何損害或損失，路透不承擔任何責任。)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2542468319"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542468319\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2542468319?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-06-10 19:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542468319","market":"us","top_or_hot":-1,"title":"BUZZ--美國股票走勢-諾和諾德、TechTarget、Unicycive Therapeutics","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ--美國股票走勢-<a href=\"https://laohu8.com/S/NVO\">諾和諾德</a>、<a href=\"https://laohu8.com/S/TTGT\">TechTarget</a>、Unicycive <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a></title></head><body><div><p>個股走勢的 Eikon 搜索字符串：<span>STXBZ</span></p><p>The Day Ahead時事通訊：https://refini.tv/3LI4BU7</p><p>新聞早報》通訊：https://refini.tv/3dKUyB8</p></div><p><span>6月10日</span><span> - </span>美國股指期貨週二升跌不一，投資者在等待美國和中國之間正在進行的貿易談判的結果 (link)，談判旨在為今年以來令全球市場遭受重創的關稅爭端降溫。 <span>.N</span></p><p>** Novo Nordisk A/S &lt; NVO.N (link) &gt;:BUZZ - 在有關Parvus建築股份的報告發布後，股價上漲。   <span>nL8N3SD0CF</span> </p><p>** TechTarget Inc &lt; TTGT.O (link) &gt;:BUZZ - JP <a href=\"https://laohu8.com/S/JPM\">摩根大通</a>下調評級後股價下跌   <span>nL4N3SD0JU</span> </p><p>** Unicycive Therapeutics Inc &lt; UNCY.O (link) &gt;:BUZZ - 因 FDA 指出腎病藥物存在生產問題而暴跌   <span>nL4N3SD0NU</span> </p><p>** Recursion Pharmaceuticals Inc &lt; RXRX.O (link) &gt;:BUZZ - 在裁員 20% 後上漲  <span>nL4N3SD0OS</span> </p><p>** J.M. Smucker Co &lt; SJM.N (link) &gt;:BUZZ - 在下調年度盈利預測後下跌   <span>nL6N3SD0II</span> </p><p>(為便利非英文母語者，路透將其報導自動化翻譯為數種其他語言。由於自動化翻譯可能有誤，或未能包含所需語境，路透不保證自動化翻譯文本的準確性，僅是為了便利讀者而提供自動化翻譯。對於因為使用自動化翻譯功能而造成的任何損害或損失，路透不承擔任何責任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ--美國股票走勢-諾和諾德、TechTarget、Unicycive Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ--美國股票走勢-諾和諾德、TechTarget、Unicycive Therapeutics\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time smaller\">2025-06-10 19:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ--美國股票走勢-<a href=\"https://laohu8.com/S/NVO\">諾和諾德</a>、<a href=\"https://laohu8.com/S/TTGT\">TechTarget</a>、Unicycive <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a></title></head><body><div><p>個股走勢的 Eikon 搜索字符串：<span>STXBZ</span></p><p>The Day Ahead時事通訊：https://refini.tv/3LI4BU7</p><p>新聞早報》通訊：https://refini.tv/3dKUyB8</p></div><p><span>6月10日</span><span> - </span>美國股指期貨週二升跌不一，投資者在等待美國和中國之間正在進行的貿易談判的結果 (link)，談判旨在為今年以來令全球市場遭受重創的關稅爭端降溫。 <span>.N</span></p><p>** Novo Nordisk A/S &lt; NVO.N (link) &gt;:BUZZ - 在有關Parvus建築股份的報告發布後，股價上漲。   <span>nL8N3SD0CF</span> </p><p>** TechTarget Inc &lt; TTGT.O (link) &gt;:BUZZ - JP <a href=\"https://laohu8.com/S/JPM\">摩根大通</a>下調評級後股價下跌   <span>nL4N3SD0JU</span> </p><p>** Unicycive Therapeutics Inc &lt; UNCY.O (link) &gt;:BUZZ - 因 FDA 指出腎病藥物存在生產問題而暴跌   <span>nL4N3SD0NU</span> </p><p>** Recursion Pharmaceuticals Inc &lt; RXRX.O (link) &gt;:BUZZ - 在裁員 20% 後上漲  <span>nL4N3SD0OS</span> </p><p>** J.M. Smucker Co &lt; SJM.N (link) &gt;:BUZZ - 在下調年度盈利預測後下跌   <span>nL6N3SD0II</span> </p><p>(為便利非英文母語者，路透將其報導自動化翻譯為數種其他語言。由於自動化翻譯可能有誤，或未能包含所需語境，路透不保證自動化翻譯文本的準確性，僅是為了便利讀者而提供自動化翻譯。對於因為使用自動化翻譯功能而造成的任何損害或損失，路透不承擔任何責任。)</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0310799852.SGD","symbol_name":"FTIF - Templeton Global Equity Income A MDIS SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nL4S3SD0RU:1","article_id":"2542468319","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542468319","pubTimestamp":1749555539,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":".N** Novo Nordisk A/S < NVO.N  >:BUZZ - 在有關Parvus建築股份的報告發布後，股價上漲。nL8N3SD0CF ** TechTarget Inc < TTGT.O  >:BUZZ - JP 摩根大通下調評級後股價下跌   nL4N3SD0JU ** Unicycive Therapeutics Inc < UNCY.O  >:BUZZ - 因 FDA 指出腎病藥物存在生產問題而暴跌   nL4N3SD0NU ** Recursion Pharmaceuticals Inc < RXRX.O  >:BUZZ - 在裁員 20% 後上漲  nL4N3SD0OS ** J.M. Smucker Co < SJM.N  >:BUZZ - 在下調年度盈利預測後下跌   nL6N3SD0II (為便利非英文母語者，路透將其報導自動化翻譯為數種其他語言。對於因為使用自動化翻譯功能而造成的任何損害或損失，路透不承擔任何責任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","INF.UK":"英富曼集团","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0149725797.USD":"汇丰美国股市经济规模基金","IE00BHPRN162.USD":"BNY MELLON BLOCKCHAIN INNOVATION \"B\" (USD) ACC","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","BK4139":"生物科技","BK4611":"AI医疗","UNCY":"Unicycive Therapeutics, Inc.","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","BK4022":"陆运","BK4566":"资本集团","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU1629891620.HKD":"ALLIANZ INCOME AND GROWTH \"AMG2\" (H2-HKD) INC","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","TTGT":"TechTarget","ARCB":"ArcBest Corporation","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","BK4504":"桥水持仓","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","SJM":"斯马克","BK4232":"货物陆运","IE00BJTD4V19.USD":"NEUBERGER BERMAN US LONG SHORT EQUITY \"A1\" (USD) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU2054465674.USD":"UBS (LUX) KEY SELEC SICAV DIGITAL TRANSFORMATION T \"P\" (USD) ACC","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4539":"次新股","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC"},"translate_title":"BUZZ--US Stock Moves-Novo Nordisk, TechTarget, Unicycive Therapeutics","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARCB":0.9,"INF.UK":0.9,"SJM":0.9,"TTGT":0.9,"UNCY":0.9},"content_text":"BUZZ--美國股票走勢-諾和諾德、TechTarget、Unicycive Therapeutics個股走勢的 Eikon 搜索字符串：STXBZThe Day Ahead時事通訊：https://refini.tv/3LI4BU7新聞早報》通訊：https://refini.tv/3dKUyB86月10日 - 美國股指期貨週二升跌不一，投資者在等待美國和中國之間正在進行的貿易談判的結果 (link)，談判旨在為今年以來令全球市場遭受重創的關税爭端降温。 .N** Novo Nordisk A/S < NVO.N (link) >:BUZZ - 在有關Parvus建築股份的報告發布後，股價上漲。   nL8N3SD0CF ** TechTarget Inc < TTGT.O (link) >:BUZZ - JP 摩根大通下調評級後股價下跌   nL4N3SD0JU ** Unicycive Therapeutics Inc < UNCY.O (link) >:BUZZ - 因 FDA 指出腎病藥物存在生產問題而暴跌   nL4N3SD0NU ** Recursion Pharmaceuticals Inc < RXRX.O (link) >:BUZZ - 在裁員 20% 後上漲  nL4N3SD0OS ** J.M. Smucker Co < SJM.N (link) >:BUZZ - 在下調年度盈利預測後下跌   nL6N3SD0II (為便利非英文母語者，路透將其報導自動化翻譯為數種其他語言。由於自動化翻譯可能有誤，或未能包含所需語境，路透不保證自動化翻譯文本的準確性，僅是為了便利讀者而提供自動化翻譯。對於因為使用自動化翻譯功能而造成的任何損害或損失，路透不承擔任何責任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}